← Browse by Condition
Medical Condition

acute coronary syndromes

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for acute coronary syndromes sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — acute coronary syndromes Clinical Trials

How many clinical trials are currently recruiting for acute coronary syndromes?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for acute coronary syndromes, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for acute coronary syndromes?
acute coronary syndromes research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a acute coronary syndromes clinical trial?
Eligibility criteria for acute coronary syndromes trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Shahid Beheshti University of Medical Sciences 1 trial
Jilin University 1 trial
Gyeongsang National University Hospital 1 trial
Gadjah Mada University 1 trial

Recruiting Clinical Trials

NCT07123181
Recruiting
Oregano and Basil Leaves and Coronary Artery Disease
Enrollment
70 pts
Location
Iran
Sponsor
Shahid Beheshti University of ...
View Trial →
NCT07846462
Recruiting
Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI
Enrollment
2,640 pts
Location
China
Sponsor
Jilin University
View Trial →
NCT07684742 Phase 4
Recruiting
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Enrollment
2,200 pts
Location
South Korea
Sponsor
Gyeongsang National University...
View Trial →
NCT06625463
Recruiting
Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS)
Enrollment
90 pts
Location
Indonesia
Sponsor
Gadjah Mada University
View Trial →

Related Conditions

unstable angina ua (1) coronary artery disease (1) chronic coronary syndrome (1) percutaneous coronary intervention (1) stemi (1) nstemi (1) unstable angina (1) home based rehabilitation (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology